Full endoscopy and minimally invasive transforaminal lumbar interbody fusion in the treatment of 1-2 degree spondylolisthesis with Lumbar Spinal Stenosis:a prospective controlled Trial

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000040472

Enrollment

Unknown

Registered

2020-11-29

Start date

2021-01-01

Completion date

Unknown

Last updated

2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1-2 degree spondylolisthesis with Lumbar Spinal Stenosis

Interventions

Experimental group:Full endoscopy transforaminal lumbar interbody fusion

Control group:Minimally invasive transforaminal lumbar interbody fusion

Eligibility

Sex/Gender

All

Age

20 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Chronic low back pain with neurological symptoms on lower extremity is not effective after more than 3 months of conservative treatment; 2. Imaging examination showed 1-2 degree spondylolisthesis instability with Lumbar Spinal Stenosis; 3. Symptoms, signs and imaging results are consistent; 4. Obtain the patient's informed consent for surgical treatment; 5. aged 20 to 65 years.

Exclusion criteria

Exclusion criteria: 1. patients with mental disorders can not accept accurate assessment; 2. Insufficient cardiopulmonary function to tolerate general anesthesia.

Design outcomes

Primary

Measure	Time frame
the pain symptoms of back and legs;lumbar function;The final lumbar function score;Surgery-related complications;	—

Secondary

Measure	Time frame
Postoperative hospital stays;Operation time;length of time to ambulation;intraoperative blood loss;	—

Countries

China

Contacts

Public ContactZhen-Zhou Li

Department of Orthopedic Surgery, The Fourth Medical Center of Chinese PLA General Hospital

dr_lizhenzhou@163.com+86 13601266970

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026